2 results
Approved WMOCompleted
To validate the use of the Livv Mobiel ECG as a reliable office/bedside screening tool in primary care practice
Approved WMOWill not start
This is a Phase 2, open-label, multicenter trial designed to evaluate the efficacy and safety of CUDC-907 in subjects 18 years and older with RR DLBCL, including those with MYC Alterations.